IL113544A - Active peptide and its preparation - Google Patents

Active peptide and its preparation

Info

Publication number
IL113544A
IL113544A IL11354495A IL11354495A IL113544A IL 113544 A IL113544 A IL 113544A IL 11354495 A IL11354495 A IL 11354495A IL 11354495 A IL11354495 A IL 11354495A IL 113544 A IL113544 A IL 113544A
Authority
IL
Israel
Prior art keywords
val
pro
meval
me2val
terminus
Prior art date
Application number
IL11354495A
Other languages
English (en)
Hebrew (he)
Other versions
IL113544A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL113544A0 publication Critical patent/IL113544A0/xx
Priority to IL13838400A priority Critical patent/IL138384A0/xx
Publication of IL113544A publication Critical patent/IL113544A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL11354495A 1994-05-06 1995-04-28 Active peptide and its preparation IL113544A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL13838400A IL138384A0 (en) 1994-05-06 2000-09-11 Precursors for active peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4415997A DE4415997A1 (de) 1994-05-06 1994-05-06 Neuer peptidischer Wirkstoff und dessen Herstellung

Publications (2)

Publication Number Publication Date
IL113544A0 IL113544A0 (en) 1995-07-31
IL113544A true IL113544A (en) 2001-01-11

Family

ID=6517453

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11354495A IL113544A (en) 1994-05-06 1995-04-28 Active peptide and its preparation

Country Status (28)

Country Link
US (1) US5864012A (ja)
EP (1) EP0758342B1 (ja)
JP (1) JPH09512803A (ja)
KR (1) KR100336139B1 (ja)
CN (1) CN1113067C (ja)
AT (1) ATE188485T1 (ja)
AU (1) AU688037B2 (ja)
BG (1) BG61610B2 (ja)
BR (1) BR9507623A (ja)
CZ (1) CZ288448B6 (ja)
DE (2) DE4415997A1 (ja)
DK (1) DK0758342T3 (ja)
ES (1) ES2141351T3 (ja)
FI (1) FI119642B (ja)
GR (1) GR3032630T3 (ja)
HR (1) HRP950271B1 (ja)
HU (1) HU220875B1 (ja)
IL (1) IL113544A (ja)
MX (1) MX9605402A (ja)
NO (1) NO317728B1 (ja)
NZ (1) NZ285092A (ja)
PL (1) PL180652B1 (ja)
PT (1) PT758342E (ja)
RU (1) RU2153504C2 (ja)
SI (1) SI9520061B (ja)
TW (1) TW408132B (ja)
WO (1) WO1995030691A1 (ja)
ZA (1) ZA953584B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US7304750B2 (en) * 1999-12-17 2007-12-04 Nektar Therapeutics Systems and methods for non-destructive mass sensing
KR20020066476A (ko) * 2001-02-12 2002-08-19 쥬가이 세이야쿠 가부시키가이샤 펩타이드 유도체의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105651A (en) * 1992-05-20 1998-07-15 Basf Ag History of dolastatin preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
NO964688L (no) 1997-01-02
GR3032630T3 (en) 2000-05-31
KR970702880A (ko) 1997-06-10
TW408132B (en) 2000-10-11
US5864012A (en) 1999-01-26
AU688037B2 (en) 1998-03-05
FI119642B (fi) 2009-01-30
CN1113067C (zh) 2003-07-02
WO1995030691A1 (de) 1995-11-16
HU220875B1 (en) 2002-06-29
NO964688D0 (no) 1996-11-05
HUT75861A (en) 1997-05-28
HRP950271B1 (en) 2000-08-31
FI964448A0 (fi) 1996-11-05
BR9507623A (pt) 1997-10-07
MX9605402A (es) 1997-12-31
NO317728B1 (no) 2004-12-13
DE4415997A1 (de) 1995-11-09
BG61610B2 (bg) 1998-01-30
HRP950271A2 (en) 1997-08-31
PL180652B1 (pl) 2001-03-30
DE59507578D1 (de) 2000-02-10
ES2141351T3 (es) 2000-03-16
JPH09512803A (ja) 1997-12-22
KR100336139B1 (ko) 2002-09-25
SI9520061A (en) 1997-06-30
EP0758342B1 (de) 2000-01-05
HU9603067D0 (en) 1997-01-28
EP0758342A1 (de) 1997-02-19
CZ288448B6 (en) 2001-06-13
ZA953584B (en) 1996-11-04
DK0758342T3 (da) 2000-05-01
NZ285092A (en) 1998-01-26
AU2408395A (en) 1995-11-29
SI9520061B (sl) 2002-02-28
FI964448A (fi) 1996-11-05
PT758342E (pt) 2000-04-28
CN1162318A (zh) 1997-10-15
PL321159A1 (en) 1997-11-24
IL113544A0 (en) 1995-07-31
CZ326096A3 (en) 1997-04-16
ATE188485T1 (de) 2000-01-15
RU2153504C2 (ru) 2000-07-27

Similar Documents

Publication Publication Date Title
US4507235A (en) Method for preparing peptides and intermediate products
US4716235A (en) Process for preparing N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline
US4331592A (en) Process for the preparation of carboxylic acid amides and peptides
EP2121605B1 (en) Process for preparing (1r,2s,5s)-n-[(1s)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[(1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
EP0098865B1 (en) Peptide synthesis and amino acid blocking agents
JPH01308297A (ja) テトラペプチド
US5864012A (en) Active peptide and its preparation
WO1993021176A1 (en) Novel cyclic amino acids and derivatives thereof
US5886147A (en) Compounds useful for the synthesis of dolastatin analogs
SE452318B (sv) Aminosyror till anvendning som mellanprodukter vid framstellning av bestatiner
CA2189690C (en) Novel active peptide and its preparation
CA2223911C (en) The preparation of active peptides
EP0001174B1 (en) A peptide and the salts thereof, processes for their preparation and compositions containing them
EP0227306B1 (en) Peptide immunostimulants
US4581167A (en) Peptide synthesis and amino acid blocking agents
CN108864252B (zh) 制备nrx-1074的方法
Goodman et al. The stereocontrolled synthesis of orthogonally protected (R)-α-methyltryptophan
CN114644682A (zh) 一种硼替佐米的制备方法
Sureshbabu et al. HOAt. DCHA as co-coupling agent in the synthesis of peptides employing Fmoc-amino acid chlorides as coupling agents: Application to the synthesis of β-casomorphin
JPH082916B2 (ja) ペプチド誘導体類及びそれらの製造方法
JPH0819070B2 (ja) 脂肪族アミドまたはその塩の製法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired